A Guidebook to Generic Drug registration in India | Based upon International Standards

Chinmaya Chidananda Behera (u. a.)

ISBN 10: 6139962498 / ISBN 13: 9786139962495

Published by LAP LAMBERT Academic Publishing, 2018

About this Item

A Guidebook to Generic Drug registration in India | Based upon International Standards | Chinmaya Chidananda Behera (u. a.) | Taschenbuch | 200 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139962495 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Seller Inventory # 115129951

Bibliographic Details

• Title: A Guidebook to Generic Drug registration in India | Based upon International Standards
• Publisher: LAP LAMBERT Academic Publishing
• Publication Date: 2018
• Language: English
• ISBN 10: 6139962498
• ISBN 13: 9786139962495
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 13D millimeters 220 millimeters width by 150 millimeters height by 13 millimeters depth
• Weight: 316 grams
• Seller catalogs:
  • Bücher

About this title

Synopsis

Since drugs are so-called life-saving substances, the quality, safety, and efficacy of these substances pose a unique challenge for the manufacturers as well as regulators. The drug has to undergo several phases of screening by governmental agencies before it is being placed in the market. A country like India's skill mostly lies in developing low priced generic medicines. Our infrastructure and economy do not allow us to invest like the western countries. The quality of medicines produced in India is no way inferior to any of the medicines available globally. However irony of the situation is such that India produces the best quality medicine for the world, not for itself. This is primarily because of the reason that it does not have a standard for itself. All the countries in the world starting from highly regulated markets to less regulated market have a certain form of guidelines for registration of the drugs in their own territories. This current work proposes some guidelines those can be adapted by Indian Regulatory authorities so as to enhance the quality of pharmaceutical products in India to meet international standards.